Juxtacrine effects of IL-1α precursor promote iNOS expression in vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 4 49-4, 2001, Pages

  Sasu, Sebastian ^a   Cooper, Angela L ^a   Beasley, Debbie ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Interleukin 1 receptor antagonist; Tumor necrosis factor

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BLOOD VESSEL INJURY; CELL CONTACT; CELL MEMBRANE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

EID: 0035008905     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.4.h1615     Document Type: Article

References (49)

1. Austin GE, Ratliff NB, Hollman J, Tabei S, and Phillips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 6: 369-375, 1985.
2. Bailly S, Ferma B, Fay M, and Gougerot-Pocidalo MA. Paraformaldehyde fixation of LPS-stimulated human monocytes: technical parameters permitting the study of membrane IL-1 activity. Eur Cytokine Netw 1: 47-51, 1990.
3. Beasley D. Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am J Physiol Regulatory Integrative Comp Physiol 259: R38-R44, 1990.
4. Beasley D, Cohen RA, and Levinsky NG. Interleukin 1 inhibits contraction of vascular smooth muscle. J Clin Invest 83: 331-335, 1989.
5. Beasley D and Cooper A. Constitutive expression of interleukin-1α precursor promotes human vascular smooth muscle cell proliferation. Am J Physiol Heart Circ Physiol 276: H901-H912, 1999.
6. Beasley D and Eldridge M. Interleukin-1β and tumor necrosis factor-α synergistically induce NO synthase in rat vascular smooth muscle cells. Am J Physiol Regulatory Integrative Comp Physiol 266: R1197-R1203, 1994.
7. Beasley D, McGuiggin M, and Dinarello CA. Human vascular smooth muscle cells produce an intracellular form of interleukin-1 receptor antagonist. Am J Physiol Cell Physiol 269: C961-C968, 1995.
8. Beasley D, Schwartz JH, and Brenner BM. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 87: 602-608, 1991.
9. Beuscher H, Fallon R, and Colten H. Macrophage membrane interleukin 1 regulates the expression of acute phase proteins in human hepatoma hep 3B cells. J Immunol 139: 1896-1901, 1987.
10. Bosenberg MW and Massague J. Juxtacrine cell signaling molecules. Curr Biol 5: 832-838, 1993.
11. Brody D and Durum S. Membrane IL-1: IL-1α precursor binds to the plasma membrane via a lectin-like interaction. J Immunol 143: 1183-1187, 1989.
12. Brody JI, Pickering NJ, Capuzzi DM, Fink GB, Can CA, and Gomez F. Interleukin-1α as a factor in occlusive vascular disease. Am J Clin Pathol 97: 8-13, 1992.
13. Chyu KY, Dimayuga P, Zhu J, Nilsson J, Kaul S, Shah PK, and Cercek B. Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ Res 85: 1192-1198, 1999.
14. Conlon PJ, Grabstein KH, Alpert A, Prickett KS, Hopp TP, and Gillis S. Localization of human mononuclear cell interleukin 1. J Immunol 139: 98-102, 1987.
15. Dinarello CA. Biologie basis for interleukin-1 in disease. Blood 87: 2095-2147, 1996.
16. French JF, Lambert LE, and Dage RC. Nitric oxide synthase inhibitors inhibit interleukin-1β-induced depression of vascular smooth muscle. J Pharmacol Exp Ther 259: 260-264, 1991.
17. Fuhlbrigge RC, Fine S, Unanue E, and Chaplin D. Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1α cDNA. Proc Natl Acad Sci USA 85: 5649-5653, 1988.
18. Garg UC and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
19. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, and Tannebaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 126: 131-138, 1982.
20. Hassid A, Arabshari H, Bourcier T, Dhaunsi GS, and Matthews C. Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 267: H1040-H1048, 1994.
21. Hofmeister R, Mannel DN, and Falk W. Evidence for an intracellular activation loop in the IL-1 system. J Inflamm 47: 151-163, 1997.
22. Kaplanski G, Farnarier C, Kaplanski S, Porat R, Shapiro L, Bongrand P, and Dinarello C. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 84: 1-7, 1994.
23. Kleschyov AL, Muller B, Schott C, and Stoclet JC. Role of adventitial nitric oxide in vascular hyporeactivity induced by lipopolysaccharide in rat aorta. Br J Pharmacol 124: 623-626, 1998.
24. Koglin J, Glysing-Jensen T, Mudgett JS, and Russell ME. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation 97: 2059-2065, 1998.
25. Kurt-Jones EA, Beller DI, Mizel SB, and Unanue ER. Identification of a membrane-associated interleukin-1 in macrophages. Proc Natl Acad Sci USA 82: 1204-1208, 1985.
26. Lee RT, Briggs WH, Cheng GC, Rossiter HB, Libby P, and Kupper T. Mechanical deformation promotes secretion of IL-1α and IL-1 receptor antagonist. J Immunol 159: 5084-5088, 1997.
27. Libby P, Ordovas JM, Birinyi LK, and Dinarello CA. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest 78: 1432-1438, 1986.
28. Loppnow H and Libby P. Functional significance of human vascular smooth muscle cell-derived interleukin-1 in paracrine and autocrine regulation pathways. Exp Cell Res 198: 283-290, 1992.
29. Luoma JS, Stralin P, Marklund SL, Hiltunen TP, Sarkioja T, and Yla-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions. Colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol 18: 157-167, 1998.
30. Maier JAM, Statuto M, and Ragnotti G. Endogenous interleukin 1 alpha must be transported to the nucleus to exerts its activity in human endothelial cells. Mol Cell Biol 14: 1845-1851, 1994.
31. McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL, Campen CA, Chizzonite RA, and Kilian PL. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 173: 931-939, 1991.
32. McMahon GA, Garfinkel S, Prudovsky I, Hu X, and Maciag T. Intracellular precursor interleukin (IL)-1α, but not mature IL-1α, is able to regulate human endothelial cell migration in vitro. J Biol Chem 272: 28202-28205, 1997.
33. Mooradian DL, Hutsell TC, and Keefer LK. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 25: 674-678, 1995.
34. Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, and Huang PL. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 101: 1225-1232, 1998.
35. Mosley B, Urdal DL, Prickett KS, Larsen A, Cosman D, Conlon PJ, Gillis S, and Dower SK. The interleukin-1 receptor binds the human interleukin-1α precursor but not the interleukin-1β precursor. J Biol Chem 262: 2941-2944, 1987.
36. Nakaki T, Nakayama M, and Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol 189: 347-353, 1990.
37. Ravalli S, Albala A, Ming M, Szabolcs M, Barbone A, Michler RE, and Cannon PJ. Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease. Circulation 97: 2338-2345, 1998.
38. Schwartz SM, deBlois D, and O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res 77: 445-465, 1995.
39. Siders W, Klimovitz J, and Mizel S. Characterization of the structural requirements and cell type specificity of IL-1α and IL-1β secretion. J Biol Chem 268: 22170-22174, 1993.
40. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, and Gabbiani G. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle cell differentiation. J Cell Biol 103: 2787-2796, 1986.
41. Stevenson F, Torrano F, Locksley R, and Lovett D. Interleukin 1: the patterns of translation and intracellular distribution support alternative secretory mechanisms. J Cell Physiol 152: 223-231, 1992.
42. Thomae KR, Nakayama DK, Billiar TR, Simmons RL, Pitt BR, and Davies P. The effect of nitric oxide on fetal pulmonary artery smooth muscle growth. J Surg Res 59: 337-343, 1995.
43. Warner SJ, Auger KR, and Libby P. Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J Exp Med 165: 1316-31, 1987.
44. Warner SJ and Libby P. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J Immunol 142: 100-109, 1989.
45. Watanabe N and Kobayashi Y. Selective release of a processed form of interleukin 1α. Cytokine 6: 597-601, 1994.
46. Wessendorf JHM, Garfinkel S, Zhan X, Brown S, and Maciag T. Identification of a nuclear localization sequence within the structure of the human interleukin-1α precursor. J Biol Chem 268: 22100-22104, 1993.
47. Yan Z and Hansson GK. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res 82: 21-29, 1998.
48. Zhang H, Du Y, Cohen RA, Chobanian AV, and Brecher P. Adventitia as a source of inducible nitric oxide synthase in the rat aorta. Am J Hypertens 12: 467-475, 1999.
49. Zola H, Flego L, Wong YT, Macardle PJ, and Kenney JS. Direct demonstration of membrane IL-1α on the surface of circulating B lymphocytes and monocytes. J Immunol 150: 1755-1762, 1993.